Use of SPY Fluorescent Angiography to Reduce Ureteroenteric Stricture Rate Following Urinary Diversion
Launched by UNIVERSITY OF VIRGINIA · Aug 23, 2021
Trial Information
Current as of November 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is testing whether using SPY fluorescent angiography (a dye and special camera that helps doctors see blood flow) during open urinary diversion can reduce a common problem called ureteroenteric stricture—narrowing where the ureter connects to the urinary diversion. The researchers compare patients who have this SPY imaging during surgery with past patients who had the same surgery without SPY. The main goal is to see if the rate of these strictures by about 1.5 years after surgery is lower, and they also track whether people need to be readmitted within 90 days, or develop hydronephrosis, kidney infection, or other kidney problems in that first 90 days. No results are reported yet.
Who can join: adults 18 and older who are planning an open urinary diversion (not robotic) and can give informed consent. Pregnant women are excluded. If eligible, you would have SPY imaging during your surgery as part of the procedure, and then follow standard post-surgery care. The study is at the University of Virginia and is not randomized; it compares current patients to historic controls. Enrollment is focused on about 50 participants in the SPY group, with results not yet available.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing open urinary diversion
- Exclusion Criteria:
- • Inability to provide informed consent
- • Robotic-assisted urinary diversion
- • Pregnant Women
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Charlottesville, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials